Intuitive Surgical, Inc. (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company's da Vinci Surgical System consists of a surgeon's console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon's hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci Surgical System provides its operating surgeons with control, range of motion, tissue manipulation capability and three-dimensional (3-D), high-definition (HD) vision. Intuitive has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System, the da Vinci Si Surgical System, the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company's instruments and accessories include EndoWrist Instruments and da Vinci Single-Site.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Advanced Medical Equipment & Technology
- Sub-Industry: Health Care Equipment
- Symbol: NASDAQ:ISRG
- CUSIP: 46120E60
- Web: www.intuitivesurgical.com
Capitalization:- Market Cap: $38.459 billion
- Outstanding Shares: 37,150,000
Average Prices:- 50 Day Moving Avg: $990.40
- 200 Day Moving Avg: $891.23
- 52 Week Range: $610.71 - $1,054.77
P/E:- Trailing P/E Ratio: 48.86
- Foreward P/E Ratio: 45.74
- P/E Growth: 3.81
Sales & Book Value:- Annual Revenue: $2.87 billion
- Price / Sales: 13.16
- Book Value: $121.89 per share
- Price / Book: 8.34
Profitability:- EBIDTA: $1.08 billion
- Net Margins: 28.44%
- Return on Equity: 15.99%
- Return on Assets: 14.06%
Debt:- Current Ratio: 4.41%
- Quick Ratio: 4.05%
Misc:- Average Volume: 330,564 shs.
- Beta: 0.38
- Short Ratio: 4.68
Frequently Asked Questions for Intuitive Surgical (NASDAQ:ISRG)
What is Intuitive Surgical's stock symbol?
Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."
When did Intuitive Surgical's stock split? How did Intuitive Surgical's stock split work?
Shares of Intuitive Surgical split before market open on Friday, October 6th 2017. The 3-1 split was announced on Friday, August 11th 2017. The newly created shares will be payable to shareholders after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of Intuitive Surgical stock prior to the split would have 300 shares after the split.
How were Intuitive Surgical's earnings last quarter?
Intuitive Surgical, Inc. (NASDAQ:ISRG) announced its quarterly earnings data on Thursday, July, 20th. The company reported $1.98 EPS for the quarter, beating the Zacks' consensus estimate of $1.93 by $0.05. The business had revenue of $756.20 million for the quarter, compared to analysts' expectations of $724.51 million. Intuitive Surgical had a net margin of 28.44% and a return on equity of 15.99%. Intuitive Surgical's revenue for the quarter was up 12.8% on a year-over-year basis. During the same period in the prior year, the firm posted $1.87 EPS. View Intuitive Surgical's Earnings History.
When will Intuitive Surgical make its next earnings announcement?
Where is Intuitive Surgical's stock going? Where will Intuitive Surgical's stock price be in 2017?
16 analysts have issued 1 year price objectives for Intuitive Surgical's stock. Their forecasts range from $225.00 to $1,060.00. On average, they anticipate Intuitive Surgical's share price to reach $419.73 in the next twelve months. View Analyst Ratings for Intuitive Surgical.
What are analysts saying about Intuitive Surgical stock?
Here are some recent quotes from research analysts about Intuitive Surgical stock:
- 1. According to Zacks Investment Research, "Over the last three months, Intuitive Surgical was trading consistently ahead of the broader industry. While a stellar second-quarter 2017 result was a major market sentiment booster, the company gained significantly on the CE Mark approval for da Vinci X in Europe. The stock has got a further boost on the recent U.S. FDA approval of the same. A positive outlook for the coming quarters also raises our confidence in the stock. Further, incremental spending on product development and higher investments in international markets are prudent moves that are likely to drive long-term growth. The company is also expected to enhance its organizational capabilities and gain prominence in the markets of Europe and Asia. However, the da Vinci Surgical System has a long sale and purchase order cycle which might act against the company. In fact, the stock looks a tad expensive, adding to our concerns." (7/25/2017)
- 2. Cantor Fitzgerald analysts commented, "Procedure growth: Guidance for 2017 procedure growth appears to be conservative. ISRG had 17% procedure growth in the 1H and is guiding to 14-15% procedure growth for 2017, implying 11-13% procedure growth in the 2H. The first-half procedure growth came in above expectations, as gynecology (grew in low single digits) and urology (grew in mid-to-high single digits) and China (grew by well over 25%) outpaced expectations. Second-half guidance assumes slower growth in gynecology, urology, and China, one less selling day in 3Q, and lower growth in Japan due to a lack of reimbursement." (7/21/2017)
Who are some of Intuitive Surgical's key competitors?
Some companies that are related to Intuitive Surgical include Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Boston Scientific Corporation (BSX), Koninklijke Philips N.V. (PHG), Illumina (ILMN), Edwards Lifesciences Corporation (EW), Cerner Corporation (CERN), Agilent Technologies (A), Waters Corporation (WAT), ResMed (RMD), Hologic (HOLX), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR), Quidel Corporation (QDEL) and Accelerate Diagnostics (AXDX).
Who are Intuitive Surgical's key executives?
Intuitive Surgical's management team includes the folowing people:
- Lonnie M. Smith, Independent Chairman of the Board
- Gary S. Guthart Ph.D., President, Chief Executive Officer, Director
- Marshall L. Mohr, Chief Financial Officer, Senior Vice President
- Salvatore J. Brogna, Executive Vice President - Product Operations
- David J. Rosa, Executive Vice President, Chief Commercial Officer
- Mark J. Meltzer, Senior Vice President, Chief Compliance Officer, General Counsel
- Myriam J. Curet M.D., Senior Vice President, Chief Medical Officer
- Jamie E. Samath, Vice President, Corporate Controller, and Principal Accounting Officer
- Alan J. Levy Ph.D., Lead Independent Director
- Craig H. Barratt Ph.D., Independent Director
Who owns Intuitive Surgical stock?
Intuitive Surgical's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (7.34%), BlackRock Inc. (7.21%), Vanguard Group Inc. (6.79%), State Street Corp (4.24%), Bank of New York Mellon Corp (4.07%) and Koch Industries Inc. (3.74%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Eric H Halvorson, Gary S Guthart, George Stalk Jr, Jamie Samath, Keith R Leonard, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr, Michael A Friedman and Salvatore Brogna. View Institutional Ownership Trends for Intuitive Surgical.
Who sold Intuitive Surgical stock? Who is selling Intuitive Surgical stock?
Intuitive Surgical's stock was sold by a variety of institutional investors in the last quarter, including Baillie Gifford & Co., BlackRock Inc., Bank of New York Mellon Corp, Voya Investment Management LLC, State Street Corp, HealthCor Management L.P., Franklin Resources Inc. and Wells Fargo & Company MN. Company insiders that have sold Intuitive Surgical stock in the last year include Alan J Levy, Amal M Johnson, Colin Morales, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Keith R Leonard, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr, Michael A Friedman and Salvatore Brogna. View Insider Buying and Selling for Intuitive Surgical.
Who bought Intuitive Surgical stock? Who is buying Intuitive Surgical stock?
Intuitive Surgical's stock was purchased by a variety of institutional investors in the last quarter, including Koch Industries Inc., FMR LLC, Janus Henderson Group PLC, Renaissance Technologies LLC, Old Mutual Global Investors UK Ltd., TIAA CREF Investment Management LLC, UBS Asset Management Americas Inc. and Korea Investment CORP. View Insider Buying and Selling for Intuitive Surgical.
How do I buy Intuitive Surgical stock?
Shares of Intuitive Surgical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Intuitive Surgical's stock price today?
One share of Intuitive Surgical stock can currently be purchased for approximately $1,016.77.
MarketBeat Community Rating for Intuitive Surgical (NASDAQ ISRG)MarketBeat's community ratings are surveys of what our community members think about Intuitive Surgical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Intuitive Surgical (NASDAQ:ISRG) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 5 Hold Ratings, 11 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.69) |
| Consensus Price Target: | $419.73 (58.72% downside) |
Analysts' Ratings History for Intuitive Surgical (NASDAQ:ISRG)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/25/2017 | Wedbush | Reiterated Rating | Outperform | $1,060.00 | Low |  |
| 9/5/2017 | Morgan Stanley | Reiterated Rating | Overweight | | High | |
| 9/1/2017 | Royal Bank Of Canada | Reiterated Rating | Hold | $1,000.00 | N/A | |
| 7/26/2017 | Canaccord Genuity | Reiterated Rating | Hold | $290.00 -> $333.33 | Low | |
| 7/24/2017 | Citigroup Inc. | Reiterated Rating | Buy | $305.67 -> $359.33 | Low | |
| 7/22/2017 | Stifel Nicolaus | Reiterated Rating | Buy | $283.33 -> $366.67 | Medium | |
| 7/21/2017 | J P Morgan Chase & Co | Reiterated Rating | Overweight | $350.00 | High | |
| 7/21/2017 | Barclays PLC | Boost Price Target | Overweight | $290.00 -> $333.33 | High | |
| 7/21/2017 | Cantor Fitzgerald | Reiterated Rating | Hold | $350.00 | High | |
| 7/12/2017 | Wells Fargo & Company | Reiterated Rating | Outperform | $333.33 -> $350.00 | Low | |
| 7/5/2017 | Leerink Swann | Reiterated Rating | Outperform | | Medium | |
| 6/15/2017 | BTIG Research | Reiterated Rating | Hold | | Low | |
| 6/1/2017 | Bank of America Corporation | Reiterated Rating | Buy | $333.33 | Low | |
| 5/16/2017 | Goldman Sachs Group, Inc. (The) | Initiated Coverage | Buy -> Buy | $333.33 | Medium | |
| 4/25/2017 | Jefferies Group LLC | Reiterated Rating | Buy | $225.00 | Low | |
| 4/19/2017 | Evercore ISI | Boost Price Target | In-Line | $250.00 -> $261.67 | Low | |
| 8/26/2016 | Raymond James Financial, Inc. | Initiated Coverage | Outperform | | N/A | |
| 7/21/2016 | Northland Securities | Downgrade | Market Perform -> Under Perform | $200.00 | N/A | |
| 7/20/2016 | Piper Jaffray Companies | Reiterated Rating | Neutral | $203.33 -> $233.33 | N/A | |
| 4/14/2016 | Sterne Agee CRT | Reiterated Rating | Neutral | | N/A | |
| 1/22/2016 | William Blair | Reiterated Rating | Buy | | N/A | |
(Data available from 9/26/2015 forward)
Earnings History for Intuitive Surgical (NASDAQ:ISRG)Earnings History by Quarter for Intuitive Surgical (NASDAQ ISRG)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/16/2017 | | $5.93 | | | | | N/A | |
| 7/20/2017 | Q2 2017 | $1.93 | $1.98 | $724.51 million | $756.20 million | View | N/A | |
| 4/18/2017 | Q1 17 | $1.32 | $1.70 | $664.72 million | $674.20 million | View | N/A | |
| 1/24/2017 | Q416 | $2.00 | $2.03 | $739.65 million | $757.00 million | View | N/A | |
| 10/18/2016 | Q3 | $1.71 | $2.06 | $650.49 million | $682.90 million | View | Listen | |
| 7/19/2016 | Q216 | $1.66 | $1.87 | $640.69 million | $670.00 million | View | Listen | |
| 4/19/2016 | Q1 | $1.44 | $1.47 | $593.08 million | $594.50 million | View | Listen | |
| 1/21/2016 | Q4 | $1.68 | $1.96 | $655.32 million | $676.50 million | View | Listen | |
| 10/20/2015 | Q3 | $1.41 | $1.75 | $580.37 million | $590.00 million | View | Listen | |
| 7/21/2015 | Q2 | $1.33 | $1.52 | $566.86 million | $586.10 million | View | Listen | |
| 4/21/2015 | Q1 | $0.95 | $1.19 | $535.10 million | $532.10 million | View | Listen | |
| 1/22/2015 | Q4 | $1.14 | $1.39 | $599.17 million | $604.70 million | View | Listen | |
| 10/21/2014 | Q314 | $0.89 | $1.31 | $515.44 million | $550.00 million | View | Listen | |
| 7/22/2014 | Q214 | $0.92 | $0.92 | $502.23 million | $512.00 million | View | Listen | |
| 4/22/2014 | Q114 | $1.11 | $0.89 | $507.04 million | $464.70 million | View | Listen | |
| 1/23/2014 | Q413 | $1.27 | $1.43 | $576.00 million | $576.20 million | View | Listen | |
| 10/17/2013 | Q313 | $1.13 | $1.33 | $525.47 million | $499.00 million | View | Listen | |
| 7/18/2013 | Q2 2013 | $1.35 | $1.30 | $594.58 million | $578.50 million | View | Listen | |
| 4/18/2013 | Q1 2013 | $1.34 | $1.52 | $583.59 million | $611.40 million | View | Listen | |
| 1/22/2013 | Q4 2012 | $1.34 | $1.42 | $584.36 million | $609.30 million | View | Listen | |
| 10/16/2012 | | $1.17 | $1.49 | | | View | N/A | |
| 7/19/2012 | | $1.19 | $1.25 | | | View | N/A | |
| 4/17/2012 | | $1.05 | $1.17 | | | View | N/A | |
| 1/19/2012 | | $1.12 | $1.25 | | | View | N/A | |
| 10/18/2011 | | $0.94 | $1.02 | | | View | N/A | |
| 7/19/2011 | | $0.90 | $0.97 | | | View | N/A | |
| 4/19/2011 | | $0.83 | $0.86 | | | View | N/A | |
| 1/20/2011 | | $0.75 | $1.01 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Intuitive Surgical (NASDAQ:ISRG)2017 EPS Consensus Estimate: $19.08
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $3.96 | $3.96 | $3.96 |
| Q2 2017 | 1 | $4.55 | $4.55 | $4.55 |
| Q3 2017 | 1 | $4.89 | $4.89 | $4.89 |
| Q4 2017 | 1 | $5.68 | $5.68 | $5.68 |
(Data provided by Zacks Investment Research)
Dividend History for Intuitive Surgical (NASDAQ:ISRG)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Intuitive Surgical (NASDAQ:ISRG)Insider Ownership Percentage: 2.20%
Institutional Ownership Percentage: 94.23%
Insider Trades by Quarter for Intuitive Surgical (NASDAQ:ISRG)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/5/2017 | Mark J Meltzer | SVP | Sell | 500 | $1,025.00 | $512,500.00 | |
| 9/1/2017 | Salvatore Brogna | EVP | Sell | 899 | $1,001.90 | $900,708.10 | |
| 8/31/2017 | Keith R Leonard | Director | Sell | 854 | $1,000.00 | $854,000.00 | |
| 8/22/2017 | Mark J Meltzer | SVP | Sell | 500 | $982.90 | $491,450.00 | |
| 7/27/2017 | Gary S Guthart | CEO | Sell | 17,975 | $937.27 | $16,847,428.25 | |
| 7/25/2017 | Curet Myriam | SVP | Sell | 1,202 | $950.20 | $1,142,140.40 | |
| 7/25/2017 | Jamie Samath | VP | Sell | 242 | $949.01 | $229,660.42 | |
| 7/25/2017 | Michael A Friedman | Director | Sell | 1,000 | $945.60 | $945,600.00 | |
| 6/12/2017 | Mark J Meltzer | SVP | Sell | 3,000 | $887.09 | $2,661,270.00 | |
| 6/8/2017 | Mark J Rubash | Director | Sell | 3,000 | $931.51 | $2,794,530.00 | |
| 6/7/2017 | Curet Myriam | SVP | Sell | 750 | $930.00 | $697,500.00 | |
| 6/5/2017 | Curet Myriam | SVP | Sell | 2,644 | $921.26 | $2,435,811.44 | |
| 6/5/2017 | Jamie Samath | VP | Sell | 1,946 | $921.26 | $1,792,771.96 | |
| 6/1/2017 | Salvatore Brogna | EVP | Sell | 1,306 | $915.09 | $1,195,107.54 | |
| 5/31/2017 | Amal M Johnson | Director | Sell | 1,000 | $917.27 | $917,270.00 | |
| 5/5/2017 | Jamie Samath | VP | Sell | 48 | $850.00 | $40,800.00 | |
| 5/2/2017 | Curet Myriam | SVP | Sell | 3,385 | $837.21 | $2,833,955.85 | |
| 4/27/2017 | Marshall Mohr | CFO | Sell | 8,950 | $835.89 | $7,481,215.50 | |
| 4/25/2017 | Jamie Samath | VP | Sell | 626 | $825.00 | $516,450.00 | |
| 4/24/2017 | Alan J Levy | Director | Sell | 1,386 | $813.15 | $1,127,025.90 | |
| 4/21/2017 | David J. Rosa | EVP | Sell | 5,000 | $810.52 | $4,052,600.00 | |
| 4/21/2017 | Gary S Guthart | CEO | Sell | 18,775 | $810.33 | $15,213,945.75 | |
| 4/21/2017 | Jamie Samath | VP | Sell | 490 | $811.67 | $397,718.30 | |
| 4/21/2017 | Lonnie M Smith | Director | Sell | 3,000 | $810.12 | $2,430,360.00 | |
| 3/15/2017 | Amal M Johnson | Director | Sell | 1,000 | $750.00 | $750,000.00 | |
| 3/15/2017 | David J Rosa | EVP | Sell | 5,000 | $750.00 | $3,750,000.00 | |
| 3/15/2017 | Jamie Samath | VP | Sell | 4,268 | $750.00 | $3,201,000.00 | |
| 3/15/2017 | Marshall Mohr | CFO | Sell | 4,250 | $750.00 | $3,187,500.00 | |
| 3/1/2017 | Salvatore Brogna | EVP | Sell | 6,628 | $736.80 | $4,883,510.40 | |
| 2/24/2017 | Curet Myriam | SVP | Sell | 222 | $729.80 | $162,015.60 | |
| 2/21/2017 | Mark J Meltzer | SVP | Sell | 8,750 | $724.82 | $6,342,175.00 | |
| 2/7/2017 | Colin Morales | SVP | Sell | 1,000 | $703.99 | $703,990.00 | |
| 2/2/2017 | Marshall Mohr | CFO | Sell | 2,000 | $700.00 | $1,400,000.00 | |
| 1/27/2017 | Lonnie M Smith | Director | Sell | 1,000 | $684.38 | $684,380.00 | |
| 12/13/2016 | David J Rosa | EVP | Sell | 7,200 | $650.00 | $4,680,000.00 | |
| 12/13/2016 | Lonnie M Smith | Director | Sell | 1,000 | $650.00 | $650,000.00 | |
| 11/17/2016 | Lonnie M Smith | Director | Sell | 275 | $646.50 | $177,787.50 | |
| 11/7/2016 | Gary S Guthart | CEO | Sell | 13,515 | $680.68 | $9,199,390.20 | |
| 8/22/2016 | Mark J Meltzer | SVP | Sell | 3,000 | $688.33 | $2,064,990.00 | |
| 8/4/2016 | Alan J Levy | Director | Sell | 3,188 | $694.11 | $2,212,822.68 | |
| 8/1/2016 | Gary S Guthart | CEO | Sell | 13,400 | $698.00 | $9,353,200.00 | |
| 7/27/2016 | Curet Myriam | SVP | Sell | 4,250 | $684.39 | $2,908,657.50 | |
| 7/27/2016 | Marshall Mohr | CFO | Sell | 5,000 | $684.09 | $3,420,450.00 | |
| 6/2/2016 | Salvatore Brogna | EVP | Sell | 600 | $630.96 | $378,576.00 | |
| 6/1/2016 | Salvatore Brogna | EVP | Sell | 20,406 | $632.66 | $12,910,059.96 | |
| 5/17/2016 | Curet Myriam | SVP | Sell | 530 | $629.36 | $333,560.80 | |
| 5/17/2016 | Lonnie M Smith | Director | Sell | 2,000 | $627.23 | $1,254,460.00 | |
| 5/3/2016 | George Stalk Jr | Director | Sell | 7,644 | $618.70 | $4,729,342.80 | |
| 5/2/2016 | Marshall Mohr | CFO | Sell | 5,000 | $631.63 | $3,158,150.00 | |
| 4/27/2016 | Mark J Meltzer | SVP | Sell | 16,625 | $631.52 | $10,499,020.00 | |
| 4/26/2016 | Alan J Levy | Director | Sell | 542 | $631.72 | $342,392.24 | |
| 4/25/2016 | Amal M Johnson | Director | Sell | 2,500 | $640.00 | $1,600,000.00 | |
| 4/22/2016 | Curet Myriam | SVP | Sell | 8,173 | $637.75 | $5,212,330.75 | |
| 4/22/2016 | Eric H Halvorson | Director | Sell | 5,688 | $639.21 | $3,635,826.48 | |
| 3/14/2016 | Eric H Halvorson | Director | Sell | 4,438 | $593.16 | $2,632,444.08 | |
| 3/14/2016 | Mark J Meltzer | SVP | Sell | 12,500 | $589.00 | $7,362,500.00 | |
| 3/11/2016 | Curet Myriam | SVP | Sell | 2,000 | $582.50 | $1,165,000.00 | |
| 3/11/2016 | Jamie Samath | VP | Sell | 8,026 | $575.95 | $4,622,574.70 | |
| 3/10/2016 | Alan J Levy | Director | Sell | 5,000 | $569.14 | $2,845,700.00 | |
| 3/7/2016 | Colin Morales | SVP | Sell | 2,500 | $575.00 | $1,437,500.00 | |
| 3/4/2016 | Colin Morales | SVP | Sell | 884 | $571.49 | $505,197.16 | |
| 3/3/2016 | Marshall Mohr | CFO | Sell | 2,500 | $575.00 | $1,437,500.00 | |
| 3/2/2016 | Salvatore Brogna | EVP | Sell | 1,882 | $567.37 | $1,067,790.34 | |
| 2/19/2016 | Colin Morales | SVP | Sell | 5,530 | $542.83 | $3,001,849.90 | |
| 2/4/2016 | Curet Myriam | SVP | Sell | 2,000 | $551.00 | $1,102,000.00 | |
| 2/4/2016 | Marshall Mohr | CFO | Sell | 2,500 | $550.00 | $1,375,000.00 | |
| 1/29/2016 | Mark J. Meltzer | SVP | Sell | 4,125 | $527.59 | $2,176,308.75 | |
| 12/14/2015 | Salvatore Brogna | EVP | Sell | 2,734 | $530.00 | $1,449,020.00 | |
| 11/20/2015 | Mark J. Meltzer | SVP | Sell | 1,625 | $515.00 | $836,875.00 | |
| 10/26/2015 | Mark J. Meltzer | SVP | Sell | 2,500 | $498.37 | $1,245,925.00 | |
| 10/23/2015 | Lonnie M. Smith | Director | Sell | 10,328 | $500.00 | $5,164,000.00 | |
| 9/1/2015 | Salvatore Brogna | EVP | Sell | 374 | $501.99 | $187,744.26 | |
| 8/18/2015 | George Stalk Jr | Director | Sell | 4,726 | $532.03 | $2,514,373.78 | |
| 7/27/2015 | Gary S Guthart | CEO | Sell | 17,255 | $541.98 | $9,351,864.90 | |
| 7/27/2015 | Mark J Meltzer | SVP | Sell | 4,750 | $542.03 | $2,574,642.50 | |
| 7/24/2015 | David J Rosa | EVP | Sell | 2,800 | $550.20 | $1,540,560.00 | |
| 7/24/2015 | Jamie Samath | VP | Sell | 5,000 | $550.00 | $2,750,000.00 | |
| 7/24/2015 | Lonnie M Smith | Director | Sell | 20,000 | $544.62 | $10,892,400.00 | |
| 6/9/2015 | Alan J Levy | Director | Sell | 417 | $495.41 | $206,585.97 | |
| 6/8/2015 | Gary S Guthart | CEO | Sell | 17,840 | $492.16 | $8,780,134.40 | |
| 5/29/2015 | Lonnie M Smith | Director | Sell | 2,000 | $488.68 | $977,360.00 | |
| 5/27/2015 | Curet Myriam | SVP | Sell | 1,000 | $489.35 | $489,350.00 | |
| 5/18/2015 | Colin Morales | SVP | Sell | 13,824 | $503.29 | $6,957,480.96 | |
| 4/28/2015 | Curet Myriam | SVP | Sell | 261 | $504.54 | $131,684.94 | |
| 4/27/2015 | Jerome J Mcnamara | EVP | Sell | 15,000 | $504.06 | $7,560,900.00 | |
| 4/27/2015 | Marshall Mohr | CFO | Sell | 10,000 | $504.08 | $5,040,800.00 | |
| 4/24/2015 | Lonnie M Smith | Director | Sell | 20,000 | $508.03 | $10,160,600.00 | |
| 3/2/2015 | Salvatore Brogna | SVP | Sell | 1,375 | $500.98 | $688,847.50 | |
| 2/6/2015 | Mark J Rubash | Director | Sell | 5,000 | $520.00 | $2,600,000.00 | |
| 1/27/2015 | Jerome J Mcnamara | EVP | Sell | 15,000 | $511.32 | $7,669,800.00 | |
| 1/27/2015 | Lonnie M Smith | Director | Sell | 20,000 | $511.31 | $10,226,200.00 | |
| 1/27/2015 | Marshall Mohr | CFO | Sell | 5,000 | $511.14 | $2,555,700.00 | |
| 12/8/2014 | Lonnie M Smith | Director | Sell | 1,700 | $511.24 | $869,108.00 | |
| 12/1/2014 | Salvatore Brogna | SVP | Sell | 1,375 | $515.87 | $709,321.25 | |
| 11/24/2014 | Colin Morales | SVP | Sell | 9,565 | $520.82 | $4,981,643.30 | |
| 10/31/2014 | Marshall Mohr | CFO | Sell | 7,500 | $500.00 | $3,750,000.00 | |
| 10/30/2014 | Floyd D Md Loop | Director | Sell | 2,125 | $488.95 | $1,039,018.75 | |
| 10/27/2014 | Floyd D Md Loop | Director | Sell | 15,209 | $475.71 | $7,235,073.39 | |
| 10/27/2014 | Jerome J Mcnamara | EVP | Sell | 15,000 | $473.76 | $7,106,400.00 | |
| 10/27/2014 | Marshall Mohr | CFO | Sell | 2,500 | $473.50 | $1,183,750.00 | |
| 9/2/2014 | Salvatore Brogna | SVP | Sell | 12,626 | $472.06 | $5,960,229.56 | |
| 8/26/2014 | Colin Morales | SVP | Sell | 4,105 | $478.66 | $1,964,899.30 | |
| 7/28/2014 | Jerome J Mcnamara | EVP | Sell | 9,167 | $465.59 | $4,268,063.53 | |
| 7/25/2014 | Colin Morales | SVP | Sell | 2,000 | $461.99 | $923,980.00 | |
| 2/27/2014 | Colin Morales | SVP | Sell | 1,000 | $445.00 | $445,000.00 | |
| 12/3/2012 | Lonnie M Smith | Chairman | Sell | 1,000 | $525.98 | $525,980.00 | |
| 9/4/2012 | Salvatore Brogna | SVP | Sell | 1,250 | $490.25 | $612,812.50 | |
(Data available from 1/1/2013 forward)
Headline Trends for Intuitive Surgical (NASDAQ:ISRG)
Latest Headlines for Intuitive Surgical (NASDAQ:ISRG)
| Source: |
|
| Date | Headline |
|---|
 | Intuitive Surgical's (ISRG) Outperform Rating Reiterated at Wedbush
www.americanbankingnews.com - September 25 at 6:00 PM |
 | A Stellar Start for a Robotics ETF - Investopedia
www.investopedia.com - September 20 at 11:39 PM |
 | Omega Flex, Inc. (OFLX) Ex-Dividend Date Scheduled for September 21, 2017 - Nasdaq
www.nasdaq.com - September 20 at 4:27 PM |
| Zimmer Biomet Holdings, Inc. (ZBH) Ex-Dividend Date Scheduled for September 21, 2017 - Nasdaq
www.nasdaq.com - September 20 at 4:27 PM |
 | A Stellar Start for a Robotics ETF
finance.yahoo.com - September 20 at 4:27 PM |
| Intuitive Surgical, Inc. (ISRG) Shares Scheduled to Split on Friday, October 6th
www.americanbankingnews.com - September 20 at 1:22 AM |
| 3 Stocks to Hold for the Next Century
finance.yahoo.com - September 17 at 7:02 PM |
| How Much Higher Can Medtech Climb As Investors Flee Pharma?
finance.yahoo.com - September 15 at 2:13 AM |
 | 4 Reasons to Buy Intuitive Surgical, Inc. Stock and Never Sell - Motley Fool
www.fool.com - September 12 at 9:52 PM |
 | Analysts have raised, or lowered, their price targets the most on these US stocks - MarketWatch
www.marketwatch.com - September 11 at 8:53 PM |
| 4 Reasons to Buy Intuitive Surgical, Inc. Stock and Never Sell
www.fool.com - September 11 at 9:00 AM |
| Is a Med-Tech Marriage in Mazor Robotics' Future?
finance.yahoo.com - September 10 at 5:49 AM |
| $752.33 Million in Sales Expected for Intuitive Surgical, Inc. (ISRG) This Quarter
www.americanbankingnews.com - September 9 at 2:54 AM |
| Intuitive Surgical Stock Just Set Another All-Time High: Is It Still a Buy? - Motley Fool
www.fool.com - September 9 at 12:48 AM |
| Noteworthy Wednesday Option Activity: FB, ADI, ISRG - Nasdaq
www.nasdaq.com - September 6 at 7:57 PM |
| Intuitive Surgical Stock Just Set Another All-Time High: Is It Still a Buy?
www.fool.com - September 6 at 3:13 PM |
| Intuitive Surgical, Inc. (ISRG) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 6 at 2:36 PM |
| Mark J. Meltzer Sells 500 Shares of Intuitive Surgical, Inc. (ISRG) Stock
www.americanbankingnews.com - September 5 at 7:46 PM |
| Intuitive Surgical Traded at Its 52-Week High on August 31
finance.yahoo.com - September 4 at 6:52 PM |
| Strategic Investments Drive Intuitive Surgical’s Future Growth
finance.yahoo.com - September 4 at 6:52 PM |
| Intuitive Surgical: Most Analysts Recommend a ‘Buy’
finance.yahoo.com - September 2 at 6:53 PM |
| 3 Reasons Intuitive Surgical, Inc. Stock Could Rise
www.fool.com - September 2 at 10:34 AM |
| Intuitive Surgical, Inc. (ISRG) Given "Hold" Rating at Royal Bank Of Canada
www.americanbankingnews.com - September 2 at 6:56 AM |
| Intuitive Surgical Plans to Expand in Europe and Asia
finance.yahoo.com - September 2 at 12:44 AM |
| Intuitive Surgical, Inc. (ISRG) EVP Sells $900,708.10 in Stock
www.americanbankingnews.com - September 1 at 7:20 PM |
| Intuitive Surgical, Inc. (ISRG) Director Keith R. Leonard Sells 854 Shares
www.americanbankingnews.com - September 1 at 1:14 PM |
| Intuitive Surgical (ISRG) Well Poised on Procedural Business - Nasdaq
www.nasdaq.com - September 1 at 1:04 AM |
| 2 Reasons Intuitive Surgical, Inc. Stock Could Fall
www.fool.com - August 31 at 7:42 PM |
| Intuitive Surgical, Inc. (ISRG) Upgraded by Vetr Inc. to "Buy"
www.americanbankingnews.com - August 28 at 5:02 PM |
| If You Love Intuitive Surgical, You Should Check Out This Small-Cap Growth Stock
www.fool.com - August 28 at 9:22 AM |
| Intuitive Surgical, Inc. – Value Analysis (NASDAQ:ISRG) : August 24, 2017
finance.yahoo.com - August 25 at 7:15 AM |
| Intuitive Surgical Stock Split: Everything You Need to Know
www.fool.com - August 20 at 8:49 AM |
| $5.82 EPS Expected for Intuitive Surgical, Inc. (ISRG) This Quarter
www.americanbankingnews.com - August 20 at 6:18 AM |
| Intuitive Surgical, Inc. (ISRG) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - August 18 at 10:50 PM |
| ETFs with exposure to Intuitive Surgical, Inc. : August 18, 2017
finance.yahoo.com - August 18 at 7:49 PM |
| Intuitive Surgical, Inc. (ISRG) Stock Rating Upgraded by Vetr Inc.
www.americanbankingnews.com - August 18 at 12:34 AM |
| See what the IHS Markit Score report has to say about Intuitive Surgical Inc.
finance.yahoo.com - August 16 at 1:59 AM |
| Colorado pediatric-surgery tech maker reaches deal with California's Intuitive Surgical
finance.yahoo.com - August 16 at 1:59 AM |
| Intuitive Surgical, Inc. Stock Set to Split on Thursday, August 31st (NASDAQ:ISRG)
www.americanbankingnews.com - August 15 at 1:26 AM |
| Intuitive Surgical's 3-for-1 stock split seen as a 'positive sign' - MarketWatch
www.marketwatch.com - August 14 at 11:14 PM |
| Intuitive Surgical, Inc. breached its 50 day moving average in a Bullish Manner : ISRG-US : August 14, 2017
finance.yahoo.com - August 14 at 11:14 PM |
| Intuitive Surgical's 3-for-1 stock split seen as a 'positive sign'
finance.yahoo.com - August 14 at 11:14 PM |
| How Intuitive Surgical, Inc. Makes Most of Its Money - Motley Fool
www.fool.com - August 14 at 4:31 AM |
| Intuitive Surgical, Inc. (ISRG) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - August 12 at 2:50 PM |
| How Intuitive Surgical, Inc. Makes Most of Its Money
www.fool.com - August 12 at 2:19 PM |
 | BRIEF-Intuitive Surgical board of directors approves a three-for-one stock split
www.reuters.com - August 12 at 5:28 AM |
 | Intuitive Surgical (ISRG) Approves 3-for-1 Stock Split
www.streetinsider.com - August 12 at 5:28 AM |
| Intuitive Surgical plans stock split as shares near $1000 - MarketWatch
www.marketwatch.com - August 12 at 12:25 AM |
| IHS Markit Score Update: Drop in demand for ETFs holding Intuitive Surgical Inc is a negative sign for its shares
finance.yahoo.com - August 12 at 12:25 AM |
| Intuitive Surgical Board of Directors Approves a Three-for-One Stock Split
finance.yahoo.com - August 12 at 12:25 AM |
Intuitive Surgical (ISRG) Chart for Tuesday, September, 26, 2017
